Unicon Pharma Inc
US H-1B Labor Condition Application activity for Unicon Pharma Inc. Filed 679 disclosures between FY2014 and FY2026 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of Unicon Pharma Inc’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 75.6% |
| Cert-withdrawn | 22.1% |
| Withdrawn | 1.9% |
| Denied | 0.4% |
Top occupations sponsored
SOC codes filed most by Unicon Pharma Inc across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 17-2112 | Industrial Engineers | 334 |
| 2 | 13-1041 | Compliance Officers | 103 |
| 3 | 15-2051 | Data Scientists | 54 |
| 4 | 15-1253 | Software Quality Assurance Analysts and Testers | 16 |
| 5 | 19-1042 | Medical Scientists, Except Epidemiologists | 14 |
| 6 | 29-1141 | Registered Nurses | 11 |
| 7 | 13-1111 | Management Analysts | 11 |
| 8 | 13-2051 | Financial and Investment Analysts | 7 |
| 9 | 19-4021 | Biological Technicians | 7 |
| 10 | 13-1161 | Market Research Analysts and Marketing Specialists | 6 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2014 | 19 |
| FY2015 | 55 |
| FY2016 | 82 |
| FY2017 | 80 |
| FY2018 | 72 |
| FY2019 | 107 |
| FY2020 | 17 |
| FY2021 | 16 |
| FY2022 | 4 |
| FY2023 | 38 |
| FY2024 | 69 |
| FY2025 | 72 |
| FY2026 | 48 |
| Period | Value |
|---|---|
| FY2014 | 19 |
| FY2015 | 55 |
| FY2016 | 82 |
| FY2017 | 80 |
| FY2018 | 72 |
| FY2019 | 107 |
| FY2020 | 17 |
| FY2021 | 16 |
| FY2022 | 4 |
| FY2023 | 38 |
| FY2024 | 69 |
| FY2025 | 72 |
| FY2026 | 48 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.